Compare Unilever plc (UL) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Unilever plc vs Zoetis Inc — how do they compare? Unilever plc trades at $61.75 (market cap $134.06B), while Zoetis Inc trades at $73.54 (market cap $31.14B). The key difference: Unilever plc is far larger — about 4.3× Zoetis Inc's market cap, and Unilever plc pays the higher dividend (3.65%). Which is the better fit depends on your goals.
| UL | ZTS | |
|---|---|---|
Market Cap | $134.06B | $31.14B |
Sector | Consumer Staples | Health |
52-Week High | $74.59 | $156.76 |
52-Week Low | $55.05 | $71.91 |
Enterprise Value | $159.86B | $38.70B |
Dividend Yield | 3.65% | 2.81% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Unilever (UL) trades at $61.75, down 1.77% with bearish technical signals. The company reported strong Q2 2026 results with 5.8% underlying sales growth - the strongest in a decade - prompting a raised full-year outlook. Despite recent earnings misses, UL maintains robust profitability with 18.75% net margins and 53.32% ROE. The pending $65 billion McCormick merger and potential Thorne acquisition signal strategic expansion.
UL presents a mixed outlook with strong fundamentals offset by recent underperformance. The merger potential offers growth catalysts, but consecutive earnings misses and bearish technicals warrant caution. Analyst consensus leans neutral (51% Hold) with balanced buy/sell ratings. Key risks include integration challenges and competitive pressures in consumer goods.
Zoetis (ZTS) trades at $73.4, down 1.95% on the day, as technical indicators signal a bearish trend amid recent price weakness. Fundamentally, the company reported Q2 2026 EPS of $1.87, beating estimates, but revenue was flat and full-year guidance was cut due to softer pet healthcare demand. Analyst sentiment remains mixed with a consensus price target of $94.90, though recent news highlights competitive pressures and a securities class action lawsuit.
The stock presents a value opportunity given its attractive P/E of 12.29 and strong profitability margins, but near-term headwinds from U.S. companion-animal market challenges and legal overhangs pose risks. Upside depends on execution against revised 2026 targets and stabilization in core markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Unilever plc
Unilever is a diversified personal product (42% of 2021 sales by value), home care (20%), and packaged food (38%) company. Its brands include Knorr soups and sauces, Hellmann's mayonnaise, Lipton teas, Axe and Dove skin products, and the TRESemme haircare brand. The firm has been acquisitive in recent years
Read more on UL →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
